Mr. Ketan Paranjape is Vice President Diagnostic Information Systems at Roche where he oversees Roche's new Diagnostics Information Solutions (DIS) commercial business. The DIS business aims to harness the power of data, diagnostics and other critical information to support better clinical decisions. Mr. Ketan Paranjape has been the Head of Business Development at Health2047, Inc. since January 2017. Mr. Paranjape served as General Manager of Life Sciences and Analytics at Intel Corporation. He is a global healthcare and life sciences business leader with a track record of identifying new business opportunities, developing products and solutions, business development, sales and marketing, developing high-performance teams and delivering exceptional financial results. During his 19-year tenure at Intel, he has run corporate-wide Big Data and Analytics programs in healthcare and life sciences, effected internal (R&D, policy, sales, marketing) and external (technology, providers, payers, pharma) partnerships to develop and deliver market-specific solutions, run research programs at top universities and spearheaded the creation of solutions that blend aspects of Big Data Analytics with High Performance Computing in the areas of genomics, clinical decision support, fraud detection, population risk management and cloud-based analytics. Mr. Paranjape holds MS degrees in Electrical Engineering and Computer Sciences from the University of Wisconsin and an MBA from the University of Oregon. He also completed the Stanford Executive Program as well as Coursework in Healthcare Management at the Harvard School of Public Health.